ALPCO

Founded in 1991, ALPCO, part of NuvinkaDx, develops immunodiagnostic and molecular diagnostic technologies for life science research, translational studies and clinical laboratories. Its expertise spans biomarker analysis, immunoassays, molecular testing and laboratory automation. The company provides tools that enable researchers to detect, quantify and monitor clinically relevant analytes across diverse sample types. ALPCO supports applications in gastroenterology, immunology, allergy, infectious disease, endocrinology, diabetes, obesity and metabolic research. Its diagnostic platforms are designed to improve workflow efficiency while delivering robust analytical performance for research and laboratory testing.

Europa Biosite’s subsidiaries distribute for ALPCO in Austria, Belgium, Ireland, Luxembourg, Netherlands and the United Kingdom.